T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report issued on Thursday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of NASDAQ TTOO opened at $0.21 on Thursday. The stock’s 50 day moving average price is $0.36 and its two-hundred day moving average price is $1.65. T2 Biosystems has a 52-week low of $0.20 and a 52-week high of $6.95.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.